Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory
Biotech
Lilly's oral GLP-1 charts 10.5% weight loss in diabetic patients
With another orforglipron trial already in the books, Lilly has unveiled the rest of the data underpinning the med's obesity approval bid.
Fraiser Kansteiner
Aug 26, 2025 6:45am
Baxter's infusion pump safety issues grow in scope
Aug 18, 2025 11:00am
Apple Watch gets blood oxygen tracking back with software update
Aug 14, 2025 11:30am
FDA formally kicks off medical device user fee negotiations
Aug 4, 2025 4:45pm
Mendaera scores FDA clearance for handheld needle robot system
Jul 9, 2025 10:30am
Martin Makary outlines AI plans, broad vision for FDA leadership
May 15, 2025 12:00pm
